117 related articles for article (PubMed ID: 24767895)
1. Livin, a novel marker in lymphoma type distinction.
Tanhaei AP; Ziaei A; Mazrouei S; Keyhanian K; Salehi M
Ann Diagn Pathol; 2014 Jun; 18(3):157-62. PubMed ID: 24767895
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of Livin expression in non-Hodgkin's lymphoma].
Gao JM; Wang X; Liu XQ; Ge XL; Ding M; Wang LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):385-90. PubMed ID: 20416174
[TBL] [Abstract][Full Text] [Related]
3. The value of CD23 expression as an additional marker in distinguishing mediastinal (thymic) large B-cell lymphoma from Hodgkin lymphoma.
Salama ME; Rajan Mariappan M; Inamdar K; Tripp SR; Perkins SL
Int J Surg Pathol; 2010 Apr; 18(2):121-8. PubMed ID: 19223373
[TBL] [Abstract][Full Text] [Related]
4. [Expression of Apoptosis-related Protein Livin and Caspase-3 in Diffuse Large B Cell Lymphoma and Its Clinical Significance].
Jin L; Sui YX; Chen ZZ; Li YH; Wang LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1664-1669. PubMed ID: 29262894
[TBL] [Abstract][Full Text] [Related]
5. Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma.
Bakshi NA; Finn WG; Schnitzer B; Valdez R; Ross CW
Arch Pathol Lab Med; 2007 May; 131(5):742-7. PubMed ID: 17488159
[TBL] [Abstract][Full Text] [Related]
6. Expression of apoptosis associated proteins Survivin, Livin and Thrombospondin-1 in Burkitt lymphoma.
Kalungi S; Wabinga H; Bostad L
APMIS; 2013 Mar; 121(3):239-45. PubMed ID: 23030305
[TBL] [Abstract][Full Text] [Related]
7. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
[TBL] [Abstract][Full Text] [Related]
8. BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin's lymphoma from primary mediastinal large B-cell lymphoma.
Hoeller S; Zihler D; Zlobec I; Obermann EC; Pileri SA; Dirnhofer S; Tzankov A
Histopathology; 2010 Jan; 56(2):217-28. PubMed ID: 20102401
[TBL] [Abstract][Full Text] [Related]
9. High nuclear Livin expression is a favourable prognostic indicator in renal cell carcinoma.
Haferkamp A; Bedke J; Vetter C; Pritsch M; Wagener N; Buse S; Crnkovic-Mertens I; Hoppe-Seyler K; Macher-Goeppinger S; Hoppe-Seyler F; Autschbach F; Hohenfellner M
BJU Int; 2008 Dec; 102(11):1700-6. PubMed ID: 18990137
[TBL] [Abstract][Full Text] [Related]
10. Expression and role of the inhibitor of apoptosis protein livin in chemotherapy sensitivity of ovarian carcinoma.
Liu X; Wang A; Gao H; Yuan Z; Jiao Y
Int J Oncol; 2012 Sep; 41(3):1021-8. PubMed ID: 22766624
[TBL] [Abstract][Full Text] [Related]
11. Surfaceome of classical Hodgkin and non-Hodgkin lymphoma.
Hofmann A; Thiesler T; Gerrits B; Behnke S; Sobotzki N; Omasits U; Bausch-Fluck D; Bock T; Aebersold R; Moch H; Tinguely M; Wollscheid B
Proteomics Clin Appl; 2015 Aug; 9(7-8):661-70. PubMed ID: 26076441
[TBL] [Abstract][Full Text] [Related]
12. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
[TBL] [Abstract][Full Text] [Related]
13. Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin's lymphoma.
Bedewy AM; Elgammal MM; Bedewy MM; El-Maghraby SM
Ann Hematol; 2013 Oct; 92(10):1359-67. PubMed ID: 23652586
[TBL] [Abstract][Full Text] [Related]
14. Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma.
Kim HJ; Kim HK; Park G; Min SK; Cha HJ; Lee H; Choi SJ; Na HY; Choe JY; Kim JE
Diagn Pathol; 2019 Dec; 14(1):133. PubMed ID: 31831043
[TBL] [Abstract][Full Text] [Related]
15. Elevated levels of survivin and livin mRNA in bronchial aspirates as markers to support the diagnosis of lung cancer.
Li J; Chen P; Li XQ; Bao QL; Dai CH; Ge LP
Int J Cancer; 2013 Mar; 132(5):1098-104. PubMed ID: 22930255
[TBL] [Abstract][Full Text] [Related]
16. Mediastinal lymphomas: primary mediastinal (thymic) large B-cell lymphoma versus classical Hodgkin lymphoma, histopathologic dilemma solved?
Pervez S; Khawaja RD
Pathol Res Pract; 2010 Jun; 206(6):365-7. PubMed ID: 20185248
[TBL] [Abstract][Full Text] [Related]
17. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
[TBL] [Abstract][Full Text] [Related]
18. Expression of inhibitor of apoptosis protein (IAP) livin/BIRC7 in acute leukemia in adults: correlation with prognostic factors and outcome.
El-Mesallamy HO; Hegab HM; Kamal AM
Leuk Res; 2011 Dec; 35(12):1616-22. PubMed ID: 21700335
[TBL] [Abstract][Full Text] [Related]
19. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
[TBL] [Abstract][Full Text] [Related]
20. MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis.
Hsi ED; Sup SJ; Alemany C; Tso E; Skacel M; Elson P; Alonso MA; Pohlman B
Am J Clin Pathol; 2006 May; 125(5):776-82. PubMed ID: 16707382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
